Characterization of the influence of polyol fatty acid esters on the permeation of diclofenac through rat skin

被引:40
作者
Takahashi, K [1 ]
Sakano, H [1 ]
Yoshida, M [1 ]
Numata, N [1 ]
Mizuno, N [1 ]
机构
[1] Mukogawa Womens Univ, Sch Pharmaceut Sci, Dept Pharmaceut, Nishinomiya, Hyogo 6638179, Japan
关键词
percutaneous absorption; sodium diclofenac; monoesters of polyol fatty acid; sefsol; penetration enhancer; FT-IR;
D O I
10.1016/S0168-3659(01)00359-5
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In this study, we investigated the effect of sefsols on the skin to clarify the mechanism of the sefsol enhancement effect. In vitro percutaneous absorption experiments were performed using Franz diffusion cells. Removal of the stratum corneum and delipidization of the skin increased the permeation of diclofenac from aqueous suspension, with the enhancement effects being similar for both treatments. Further enhancement effects of diclofenac permeation by sefsol through the stripped and delipidized skin were not observed. Attenuated total reflectance-Fourier transform infrared spectroscopy (ATR-FTIR) was employed to investigate the biophysical changes in the stratum corneum lipids by sefsols. One of the sefsols, propylene glycol mono caprylate (S-218), induced higher and broader absorbance shifts in both asymmetric and symmetric C-H bond stretching regions. However, no significant differences were observed among the sefsols with respect to peak heights and areas for both absorbances when compared with H2O treatment. These results suggest that sefsol may change the lipid-chain fluidity of the stratum corneum without lipid extraction. The accumulated amounts of diclofenac in the skin significantly increased in the presence of sefsol. Also, the amounts of diclofenac in the skin increased with the amount of sefsol in the skin. This sefsol enhancement effect was reversed at 12 h after treatment. Thus, enhancement of the diclofenac flux by sefsols is reversible and may be due to a change in the lipid-chain fluidity of the stratum corneum and improvement in drug partitioning to the stratum corneum. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:351 / 358
页数:8
相关论文
共 19 条
[1]  
BLANK IH, 1965, J INVEST DERMATOL, V45, P240
[2]   POLYMORPHIC PHASE-BEHAVIOR OF PHOSPHOLIPID-MEMBRANES STUDIED BY INFRARED-SPECTROSCOPY [J].
CASAL, HL ;
MANTSCH, HH .
BIOCHIMICA ET BIOPHYSICA ACTA, 1984, 779 (04) :381-401
[3]   In vitro percutaneous absorption enhancement of a lipophilic drug tamoxifen by terpenes [J].
Gao, S ;
Singh, J .
JOURNAL OF CONTROLLED RELEASE, 1998, 51 (2-3) :193-199
[4]   ENHANCED PERMEATION OF POLAR COMPOUNDS THROUGH HUMAN EPIDERMIS .1. PERMEABILITY AND MEMBRANE STRUCTURAL-CHANGES IN THE PRESENCE OF SHORT-CHAIN ALCOHOLS [J].
GOATES, CY ;
KNUTSON, K .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1994, 1195 (01) :169-179
[5]   ROLE OF STRATUM-CORNEUM LIPID FLUIDITY IN TRANSDERMAL DRUG FLUX [J].
GOLDEN, GM ;
MCKIE, JE ;
POTTS, RO .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (01) :25-28
[6]   STRATUM-CORNEUM LIPID PHASE-TRANSITIONS AND WATER BARRIER PROPERTIES [J].
GOLDEN, GM ;
GUZEK, DB ;
KENNEDY, AH ;
MCKIE, JE ;
POTTS, RO .
BIOCHEMISTRY, 1987, 26 (08) :2382-2388
[7]  
INAGI T, 1981, CHEM PHARM BULL, V29, P1708
[8]  
Kitagawa S, 1999, CHEM PHARM BULL, V47, P44
[9]  
KNUTSON K, 1985, Journal of Controlled Release, V2, P67, DOI 10.1016/0168-3659(85)90034-3
[10]  
KNUTSON K, 1987, Journal of Controlled Release, V6, P59, DOI 10.1016/0168-3659(87)90064-2